Aino Health AB (publ): Aino Health AB will be listed on Nasdaq First North with first day of trade on December 16th
(Thomson Reuters ONE) -
PRESS RELEASE
December 15, 2016
NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO NEWS
DISTRIBUTORS IN THE UNITED STATES, OR FOR DISTRIBUTION IN OR INTO THE UNITED
STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH
AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR PUBLICATION WOULD
NOT BE ALLOWED BY APPLICABLE LAW.
Aino Health AB will be listed on Nasdaq First North with first day of trade on
December 16(th)
Aino Health AB (publ) ("Aino Health" or the "Company") has applied and been
approved for trade on Nasdaq First North. The first day of trade is the 16(th)
of December 2016.
The trade name for Aino Health is AINO with the ISIN-code SE0009242555. The
company's prospectus for the share issue and information about the company can
be found on the company's web site www.ainohealth.com.
Erik Penser AB is the Certified Advisor.
Important information
Publication and distribution of this press release may in certain jurisdictions
be restricted by law and persons in those jurisdictions where this press release
has been published or distributed should inform themselves about and follow such
restrictions. The information in this press release is not an offer to acquire,
subscribe for or otherwise trade in shares or another security in Aino Health.
This press release may not be released, published or distributed, directly or
indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada,
New Zealand, Singapore, South Africa or another country where such action
requires further measures in addition to what follows from Swedish law or where
this would contravene with laws or regulations of that country. The information
in this press release may not be forwarded, reproduced or disclosed in ways that
conflict with such restrictions. Omission to follow this instruction may
constitute a violation of the United States Securities Act of 1933 (the
"Securities Act") in its present terms or applicable laws in other
jurisdictions.
This information is such information that Aino Health AB (publ) is obliged to
make public pursuant to the EU Market Abuse Regulation. The information was
submitted for publication, through the agency of the contact person set out
above, at December 15, 2016 at 8:30 CET.
For more information, please contact:
Jyrki Eklund, CEO
Phone: +358 40 042 4221
E-mail: jyrki.eklund(at)ainohealth.com
Cecilia Hollerup, Chairman of the Board of Directors
Phone: +46 70 829 33 36
E-mail: cecilia.hollerup(at)holleruppartners.se
About Aino Health
Aino Health operates within Corporate Health Management. The company has
developed a complete system of IT-based services with a focus to improve
corporate health and reduce sickness absence levels in private and public
organizations.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aino Health AB (publ) via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 15.12.2016 - 08:30 Uhr
Sprache: Deutsch
News-ID 513062
Anzahl Zeichen: 3657
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 250 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Aino Health AB (publ): Aino Health AB will be listed on Nasdaq First North with first day of trade on December 16th"
steht unter der journalistisch-redaktionellen Verantwortung von
Aino Health AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
